Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

The evaluation of the neutralizing capacity of anti-SARS-CoV-2 antibodies is important because they represent real protective immunity. In this study we aimed to measure and compare the neutralizing antibodies (NAbs) in COVID-19 patients and in vaccinated individuals. One-hundred and fifty long-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Favresse, Julien, Gillot, Constant, Di Chiaro, Laura, Eucher, Christine, Elsen, Marc, Van Eeckhoudt, Sandrine, David, Clara, Morimont, Laure, Dogné, Jean-Michel, Douxfils, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309994/
https://www.ncbi.nlm.nih.gov/pubmed/34372570
http://dx.doi.org/10.3390/v13071364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309994/
https://www.ncbi.nlm.nih.gov/pubmed/34372570
http://dx.doi.org/10.3390/v13071364

Ejemplares similares